# Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs

> **NCT00979290** · — · COMPLETED · sponsor: **E-DA Hospital** · enrollment: 161 (actual)

## Conditions studied

- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00979290
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-11
- **Final completion:** 2011-11
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979290, "Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00979290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*